Skip to main content
profile image
Selected Works of Shawn Spencer
Article
The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response
Pharmacogenetics and Genomics (2013)
  • Joshua P. Lewis, University of Maryland, Baltimore
  • Richard B. Horenstein, University of Maryland, Baltimore
  • Kathleen Ryan, University of Maryland, Baltimore
  • Jeffrey R. O’Connell, University of Maryland, Baltimore
  • Quince Gibson, University of Maryland, Baltimore
  • Braxton D. Mitchell, University of Maryland, Baltimore
  • Keith Tanner, University of Maryland, Baltimore
  • Sumbul Chai, University of Maryland, Baltimore
  • Kevin P. Bliden, Sinai Hospital
  • Udaya S. Tantry, Sinai Hospital
  • Cody J. Peer, National Institutes of Health
  • William D. Figg, National Institutes of Health
  • Shawn D. Spencer, Science Applications International Corporation
  • Michael A. Pacanowski, Food and Drug Administration
  • Paul A. Gurbel
  • Alan R. Shuldiner, VA Medical Center
Link
Disciplines
Publication Date
January 1, 2013
DOI
10.1097/FPC.0b013e32835aa8a2
Citation Information
Joshua P. Lewis, Richard B. Horenstein, Kathleen Ryan, Jeffrey R. O’Connell, et al.. "The functional G143E variant of carboxylesterase 1 is associated with increased clopidogrel active metabolite levels and greater clopidogrel response" Pharmacogenetics and Genomics Vol. 23 Iss. 1 (2013) p. 1 - 8
Available at: http://works.bepress.com/shawn-spencer/16/